Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Experimental Hematology

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.exphem.2009.04.012PMID 19477219PMCID PMC5892830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular allelokaryotyping of early‐stage, untreated chronic lymphocytic leukemia

  2008cited by this paper
• Genotype, haplotype and copy-number variation in worldwide human populations

  2008cited by this paper
• ERCC5 is a novel biomarker of ovarian cancer prognosis.

  2008cited by this paper
• Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells.

  2007cited by this paper
• Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.

  2007cited by this paper
• Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.

  2007cited by this paper
• Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma

  2006influential reference
• Oncogenic PI3K and its role in cancer

  2006cited by this paper
• Global variation in copy number in the human genome

  2006cited by this paper
• Current treatment approaches for mantle-cell lymphoma.

  2005cited by this paper
• Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization.

  2005cited by this paper
• Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome.

  2005cited by this paper
• Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K‐AKT, WNT and TGFβ signalling pathways

  2005cited by this paper
• Proteomic analysis of mantle-cell lymphoma by protein microarray.

  2005cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.

  2005cited by this paper
• Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.

  2005cited by this paper
• Molecular basis of mantle cell lymphoma

  2004cited by this paper
• Large-Scale Copy Number Polymorphism in the Human Genome

  2004cited by this paper
• Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.

  2004cited by this paper
• Cell Cycle Alterations in the Blastoid Variant of Mantle Cell Lymphoma (MCL-BV) as Detected by Gene Expression Profiling of Mantle Cell Lymphoma (MCL) and MCL-BV

  2003cited by this paper
• Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene

  2002cited by this paper
• Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray.

  2001cited by this paper
• Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

  1999cited by this paper
• The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.

  1999cited by this paper
• Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features.

  1999cited by this paper
• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  1999cited by this paper
• Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems.

  1997cited by this paper
• Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.

  1997influential reference
• Mantle cell lymphoma-- an entity comes of age.

  1996cited by this paper
• Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.

  1994cited by this paper
• Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice.

  1994cited by this paper
• The cytogenetic scenario of chronic myeloid leukemia.

  1993cited by this paper

• Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

  2023cites this paper
• Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma

  2021cites this paper
• Advances in Lymphoma Molecular Diagnostics

  2021cites this paper
• Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group

  2020cites this paper
• Management of Drug Resistance in Mantle Cell Lymphoma

  2020cites this paper
• Overcoming TCF4-Driven BCR Signaling in Diffuse Large B-Cell Lymphoma

  2018cites this paper
• Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

  2017cites this paper
• Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization

  2017cites this paper
• Investigation of Rho-Kinase Expressions and Polymorphisms in Mantle Cell Lymphoma Patients

  2016cites this paper
• Lateral flow strip for visual detection of K-ras mutations based on allele-specific PCR

  2016cites this paper
• Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14

  2016cites this paper
• SNP Array in Hematopoietic Neoplasms: A Review

  2015cites this paper
• SNPs Array Karyotyping in Non-Hodgkin Lymphoma

  2015cites this paper
• Molecular Genetics of Mantle Cell Lymphoma

  2014cites this paper
• Risk factors for etiology and prognosis of mantle cell lymphoma

  2014cites this paper
• MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.

  2013cites this paper
• Array comparative genomic hybridization: an overview of protocols, applications, and technology trends.

  2013cites this paper
• Genetic differences between Asian and Caucasian chronic lymphocytic leukemia

  2013cites this paper
• Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer

  2013cites this paper
• Genomic profiling of mantle cell lymphoma.

  2013cites this paper
• FSR: feature set reduction for scalable and accurate multi-class cancer subtype classification based on copy number

  2012cites this paper
• Molecular Biology of Mantle Cell Lymphoma

  2012cites this paper
• High‐resolution genomic screening in mantle cell lymphoma—specific changes correlate with genomic complexity, the proliferation signature and survival

  2011cites this paper
• Molecular pathogenesis of mantle cell lymphoma: new perspectives and challenges with clinical implications.

  2011cites this paper
• Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers.

  2011cites this paper
• Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.

  2011cites this paper
• Genetic and Epigenetic Profiling of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

  2011cites this paper
• The complex landscape of genetic alterations in mantle cell lymphoma.

  2011cites this paper
• Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.

  2010cites this paper
• Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma.

  2010cites this paper
• Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer

  2010cites this paper
• Caractérisation épigénétique du lymphome du manteau

  2010cites this paper
• The Basis and Rational Use of Molecular Genetic Testing in Mature B-cell Lymphomas

  2010cites this paper
• microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.

  2010cites this paper
• Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.

  2010cites this paper
• microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

  2010cites this paper
• Loss of the p 53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma

  year unknowncites this paper